| NuvaRing-combined contraceptive vaginal ring: state of art in 2008. Expert Board of Polish Gynecological Society | |
| | |
MedLine Citation:
|
PMID: 19058529 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The development of steroid-releasing vaginal rings over the past three decades is reviewed to illustrate the role of this device as an effective hormonal contraceptive for women. NuvaRing is a combined contraceptive vaginal ring that releases constant low doses of ethinylestradiol and etonogestrel. The soft flexible combined ring is inserted in the vagina for three weeks and removed for seven days to allow withdrawal bleeding with no serious side-effects. Maximum levels of EE and ENG with NuvaRing were 30% and 40%, respectively, of those seen with the COC. Because ENG bioavailability was higher following vaginal administration, the systemic progestogen exposures were comparable with the oral contraceptives. NuvaRing has been shown to be safe and effective, with high levels of user compliance, acceptance and patient satisfaction. |
| | |
Authors:
|
Romuald Debski; Jan Kotarski; Tomasz Paszkowski; Leszek Pawelczyk; Violetta Skrzypulec; Jacek Tomaszewski; |
Publication Detail:
|
Type: English Abstract; Journal Article; Practice Guideline |
Journal Detail:
|
Title: Ginekologia polska Volume: 79 ISSN: 0017-0011 ISO Abbreviation: Ginekol. Pol. Publication Date: 2008 Oct |
Date Detail:
|
Created Date: 2008-12-08 Completed Date: 2008-12-31 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0374641 Medline TA: Ginekol Pol Country: Poland |
Other Details:
|
Languages: pol Pagination: 715-23 Citation Subset: IM |
Vernacular Title:
|
Stanawisko zespołu ekspertów Polskiego Towarzystwa Ginekologicznego. Dopochwowy hormonalny system antykoncepcyjny (NuvaRing)-stan wiedzy na 2008 rok. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Contraception
/
methods* Contraceptive Agents, Female / therapeutic use* Desogestrel / analogs & derivatives, therapeutic use Drug Combinations Ethinyl Estradiol / therapeutic use Female Gynecology / standards Health Knowledge, Attitudes, Practice* Humans Intrauterine Devices, Medicated / trends Natural Family Planning Methods / methods* Obstetrics / standards Patient Education as Topic Poland / epidemiology Pregnancy Pregnancy, Unplanned Women's Health |
| Chemical | |
Reg. No./Substance:
|
0/Contraceptive Agents, Female; 0/Drug Combinations; 0/NuvaRing; 54024-22-5/Desogestrel; 57-63-6/Ethinyl Estradiol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Statement of the Expert Group of Polish Gynecologic Society on the cervical adenocarcinoma prophylax...
Next Document: Carotenoids and carotenoproteins in Asellus aquaticus L. (Crustacea: Isopoda).